Amyloid Neuropathies - 25 Studies Found
| Recruiting |
: Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy :
|
| Available |
: Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) :
|
| Completed |
: ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) :
|
| Completed |
: The Effect of Diflunisal on Familial Transthyretin Amyloidosis : Amyloidosis : 2011-09-09 : Drug: Diflunisal Film-coated tablet, 250 mg twice daily, orally for approximately 2 years |
| Completed |
: Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis : Transthyretin Amyloidosis : 2010-07-27 : Drug: Doxycycline + Tauroursodeoxycholic acid doxycycline 100 mg twice a day for 12 months; tauroursodeo |
| Recruiting |
: Transthyretin-Associated Amyloidoses Outcome Survey (THAOS) :
: 2008-02-25 : Other: None. Observational Study. |
| Recruiting |
: Screening for the Transthyretin-Related Familial Amyloidotic Small Fiber Polyneuropathy :
|
| Completed |
: The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis : Transthyretin-associated Amyloidosis With Polyneuropathy : 2008-02-27 : Drug: Fx-1006A During Part 1, patients will receive Fx-1006A 20mg soft gelatin capsules once daily (at t |
| Completed |
: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis :
: 2012-04-19 :
|